Jackson Creek Investment Advisors’s Blueprint Medicines BPMC Stock Holding History

Jackson Creek Investment Advisors’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12,770	Closed	-$1.11M	–	301
2024 Q4	$1.11M	Sell	12,770 -397	-3%	-$36.4K	0.34%	155
2024 Q3	$1.22M	Buy	13,167 +2,981	+29%	+$296K	0.36%	153
2024 Q2	$1.1M	Sell	10,186 -5,278	-34%	-$528K	0.4%	95
2024 Q1	$1.47M	Sell	15,464 -34	-0.2%	-$2.92K	0.52%	17
2023 Q4	$1.43M	Buy	+15,498	New	+$1M	0.55%	17
2022 Q1	–	Sell	-10,292	Closed	-$1.1M	–	308
2021 Q4	$1.1M	Buy	+10,292	New	+$1.08M	0.39%	111
2021 Q3	–	Sell	-7,521	Closed	-$662K	–	299
2021 Q2	$662K	Sell	7,521 -708	-9%	-$64.9K	0.25%	208
2021 Q1	$800K	Sell	8,229 -245	-3%	-$24.5K	0.28%	191
2020 Q4	$950K	Buy	+8,474	New	+$893K	0.37%	136

Other funds holding BPMC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Jackson Creek Investment Advisors's BPMC Position: Q1 2025 in Review

Jackson Creek Investment Advisors sold out of Blueprint Medicines (BPMC) in Q1 2025, closing a stake of 12,770 shares — an estimated $1.11M sold.

Jackson Creek Investment Advisors first reported a position in BPMC in Q4 2020 and held it in 9 quarters. The position peaked at $1.47M in Q1 2024. 352 funds tracked by Wall St. Rank hold BPMC as of Q1 2025.

Jackson Creek Investment Advisors reported no remaining Blueprint Medicines position as of Q1 2025 after selling out during the quarter.
Jackson Creek Investment Advisors sold 12,770 Blueprint Medicines shares in Q1 2025, an estimated $1.11M.
Jackson Creek Investment Advisors first reported a position in Blueprint Medicines in Q4 2020 and held it in 9 quarters.
Jackson Creek Investment Advisors's Blueprint Medicines position peaked at $1.47M in Q1 2024.
352 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2025.

Based on Jackson Creek Investment Advisors's 13F filing for Q1 2025, filed 5 May 2025.